Rocket One Inc. Other Nonoperating Income
Rocket One Inc. (RKTO) reported Other Nonoperating Income of $149 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncome · last filed 2026-08-14
- Rocket One Inc. other nonoperating income for the quarter ending 2026-06-30 was $149.00, a 13.87% decline year-over-year.
- Rocket One Inc. other nonoperating income for the quarter ending 2025-06-30 was $173.00.
- Rocket One Inc. other nonoperating income for the quarter ending 2020-12-31 was $46.09K, a 640.50% increase year-over-year.
- Rocket One Inc. other nonoperating income for the quarter ending 2020-09-30 was $49.91K, a 1031.19% increase year-over-year.
- Rocket One Inc. other nonoperating income for fiscal 2020 was $104.16K, a 879.30% increase from fiscal 2019.
- Rocket One Inc. other nonoperating income for fiscal 2019 was $10.64K.
| Period end | Other Nonoperating Income 3 month | Other Nonoperating Income 6 month | Other Nonoperating Income 9 month | Other Nonoperating Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $149.00 10-Q · filed 2026-08-14 | $298.00 10-Q · filed 2026-08-14 | ||
| 2025-06-30 | $173.00 10-Q · filed 2026-08-14 | $354.00 10-Q · filed 2026-08-14 | ||
| 2020-12-31 | $46.09K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $96.00K derived: sum of 2 quarters · filed 2021-03-16 | $114.28K derived: sum of 3 quarters · filed 2021-03-16 | $104.16K 10-K · filed 2021-03-16 |
| 2020-09-30 | $49.91K 10-Q · filed 2020-11-10 | $68.19K derived: sum of 2 quarters · filed 2020-11-10 | $58.07K 10-Q · filed 2020-11-10 | $64.29K derived: sum of 4 quarters · filed 2021-03-16 |
| 2020-06-30 | $18.29K 10-Q · filed 2020-08-13 | $8.16K 10-Q · filed 2020-08-13 | $14.38K derived: sum of 3 quarters · filed 2021-03-16 | $18.80K derived: sum of 4 quarters · filed 2021-03-16 |
| 2020-03-31 | -$10.13K 10-Q · filed 2020-05-13 | -$3.90K derived: sum of 2 quarters · filed 2021-03-16 | $510.00 derived: sum of 3 quarters · filed 2021-03-16 | |
| 2019-12-31 | $6.22K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $10.64K derived: sum of 2 quarters · filed 2021-03-16 | $10.64K 10-K · filed 2021-03-16 | |
| 2019-09-30 | $4.41K 10-Q · filed 2020-11-10 | $4.41K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |